Viramune (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Viramune drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | nevirapine |
SUBSTANCE NAME: | NEVIRAPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-04-11 |
END MARKETING DATE: | 0000-00-00 |
Viramune HUMAN PRESCRIPTION DRUG Details:
Item Description | Viramune from Boehringer Ingelheim Pharmaceuticals, Inc. |
LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2011-04-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0597-0123_ac202b30-c476-6df3-5639-5d26165c4820 |
PRODUCT NDC: | 0597-0123 |
APPLICATION NUMBER: | NDA201152 |
Other NEVIRAPINE Pharmaceutical Manufacturers / Labelers: